Literature DB >> 17192721

Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.

H C Fung1, G Xiromerisiou, J R Gibbs, Y R Wu, J Eerola, V Gourbali, O Hellström, C M Chen, J Duckworth, A Papadimitriou, P J Tienari, G M Hadjigeorgiou, J Hardy, A B Singleton.   

Abstract

BACKGROUND: The overlap in the clinical and pathological features of tauopathies and synucleinopathies raises the possibility that the tau protein may be important in Parkinson's disease (PD) pathogenesis. Several MAPT polymorphisms that define the tau H1 haplotype have been investigated for an association with PD with conflicting results; however, two meta-analyses support an association between haplotype H1 and PD.
METHODS: In this study, we recruited 508 patients and 611 healthy controls from Greek, Finnish and Taiwanese populations. We examined the possible genetic role of variation within MAPT in PD using haplotype-tagging single polymorphisms (SNPs) in these ethnically different PD populations.
RESULTS: We identified a moderate association at SNP rs3785883 in the Greek cohort for both allele and genotype frequency (p = 0.01, p = 0.05, respectively) as well as for SNP rs7521 (genotype p = 0.02) and rs242557 (p = 0.01 genotypic, p = 0.04 allelic) in the Finnish population. There were no significant differences in genotype or allele distribution between cases and controls in the Taiwanese cohort.
CONCLUSION: We failed to demonstrate a consistent association between the MAPT H1 haplotype (delineated by intron 9 ins/del) and PD in three ethnically diverse populations. However, the data presented here suggest that subhaplotypes of haplotype H1 may confer susceptibility to PD, and that either allelic heterogeneity or different haplotype composition explain the divergent haplotype results. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192721     DOI: 10.1159/000097301

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  13 in total

Review 1.  Knock-out and transgenic mouse models of tauopathies.

Authors:  Franziska Denk; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-22       Impact factor: 4.673

2.  Genome-wide association study confirms extant PD risk loci among the Dutch.

Authors:  Javier Simón-Sánchez; Jacobus J van Hilten; Bart van de Warrenburg; Bart Post; Henk W Berendse; Sampath Arepalli; Dena G Hernandez; Rob M A de Bie; Daan Velseboer; Hans Scheffer; Bas Bloem; Karin D van Dijk; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Patrizia Rizzu; Zoltan Bochdanovits; Andrew B Singleton; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

3.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

4.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Stewart A Factor; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Denise M Kay; Dora Yearout; Jennifer S Montimurro; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

Review 5.  Model fusion, the next phase in developing animal models for Parkinson's disease.

Authors:  Amy B Manning-Bog; J William Langston
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 6.  Genetic susceptibility in Parkinson's disease.

Authors:  Jose Miguel Bras; Andrew Singleton
Journal:  Biochim Biophys Acta       Date:  2008-11-20

7.  Family-based association analysis of the MAPT gene in Parkinson disease.

Authors:  K S Wang; J E Mullersman; X F Liu
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

8.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

9.  Assessment of Parkinson's disease risk loci in Greece.

Authors:  Eleanna Kara; Georgia Xiromerisiou; Cleanthe Spanaki; Maria Bozi; Georgios Koutsis; Marios Panas; Efthimios Dardiotis; Styliani Ralli; Jose Bras; Christopher Letson; Connor Edsall; Hannah Pliner; Sampath Arepalli; Kallirhoe Kalinderi; Liana Fidani; Sevasti Bostantjopoulou; Margaux F Keller; Nicholas W Wood; John Hardy; Henry Houlden; Leonidas Stefanis; Andreas Plaitakis; Dena Hernandez; Georgios M Hadjigeorgiou; Mike A Nalls; Andrew B Singleton
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

10.  Identifying the genetic components underlying the pathophysiology of movement disorders.

Authors:  Mario Ezquerra; Yaroslau Compta; Maria J Marti
Journal:  Appl Clin Genet       Date:  2011-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.